Studies in adults and adolescents have demonstrated that tiotropium is efficacious as an add-on therapy to inhaled corticosteroids (ICSs) with or without other maintenance therapies in patients with moderate or severe symptomatic asthma.

A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma

BONER, Attilio;
In corso di stampa

Abstract

Studies in adults and adolescents have demonstrated that tiotropium is efficacious as an add-on therapy to inhaled corticosteroids (ICSs) with or without other maintenance therapies in patients with moderate or severe symptomatic asthma.
In corso di stampa
Anticholinergic drug; FEV(1); Respimat; asthma; asthma control; children; efficacy; lung function; safety; tiotropium
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/962880
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact